The Fluoroscopy Equipment market size was valued at USD 2.06 billion in 2024 and is projected to reach USD 2.37 billion by 2032, growing at a CAGR of 1.8% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Fluoroscopy Equipment market Size 2024
USD 2.06 Billion
Fluoroscopy Equipment market , CAGR
1.8%
Fluoroscopy Equipment market Size 2032
USD 2.37 Billion
The Fluoroscopy Equipment market is led by major players such as GE HealthCare, Siemens Healthineers, Koninklijke Philips NV, Canon Medical Systems Corporation, Hitachi Medical Systems, Shimadzu Corporation, Ziehm Imaging GmbH, Hologic Inc., Orthoscan Inc., and Carestream Health. These companies drive market growth through advancements in flat-panel detector technology, AI-based image enhancement, and radiation dose optimization. North America dominates the market with a 38% share, supported by strong adoption of advanced imaging systems and well-established healthcare infrastructure. Europe holds a 29% share, driven by increasing demand for digital fluoroscopy in hospitals. Asia-Pacific follows with a 27% share, propelled by rapid healthcare modernization and growing investment in diagnostic imaging facilities.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The Fluoroscopy Equipment market was valued at USD 2.06 billion in 2024 and is projected to reach USD 2.37 billion by 2032, expanding at a CAGR of 1.8% during the forecast period.
Market growth is driven by the rising adoption of minimally invasive procedures, advancements in digital imaging technology, and increased focus on radiation dose management for patient safety.
Key trends include the integration of AI-based image processing, growing use of mobile C-arms, and adoption of hybrid imaging systems to improve diagnostic accuracy and workflow efficiency.
The market features strong competition among GE HealthCare, Siemens Healthineers, Philips, and Canon Medical Systems, all focusing on innovation, strategic collaborations, and product diversification.
North America leads with a 38% share, followed by Europe with 29% and Asia-Pacific with 27%, while the C-arms segment dominates the market with a 57% share due to its flexibility and wide clinical applications.
Market Segmentation Analysis:
By Product
The C-arms segment dominated the Fluoroscopy Equipment market in 2024 with a 57% share. C-arms are widely used in surgical imaging due to their flexibility, mobility, and ability to provide real-time visualization during procedures. The demand for both fixed and mobile C-arms continues to grow, driven by the rising volume of minimally invasive surgeries and orthopedic interventions. Continuous advancements in flat-panel detectors, dose reduction technologies, and digital integration enhance clinical accuracy. Hospitals and surgical centers prefer C-arms for their high image quality, easy maneuverability, and compatibility with hybrid operating rooms.
For instance, Ziehm Imaging introduced the Vision RFD Hybrid Edition, featuring a 30 × 30 cm flat-panel detector and a liquid cooling system capable of prolonged fluoroscopy for demanding procedures. The system’s SmartDose technology offers a comprehensive concept for high image quality and minimized dose exposure, with significant savings for patients and staff.
By Application
The orthopedic segment held the largest market share of 41% in 2024, supported by the increasing prevalence of bone fractures, joint replacements, and spinal disorders. Fluoroscopy plays a vital role in guiding orthopedic surgeries and ensuring precise implant placement. The rising adoption of minimally invasive orthopedic techniques and real-time imaging solutions drives demand. Technological innovations in 3D fluoroscopy and radiation dose optimization strengthen its use in trauma and reconstructive procedures. Growing aging populations and expanding access to advanced surgical facilities further enhance segment growth globally.
For instance, the Siemens Healthineers Cios Spin system delivered intraoperative 3D imaging using its Retina 3D scan technology, which provides a maximum spatial resolution of 0.3 mm. This enabled precise navigation during spinal fusion surgeries. The system’s integration with a Metal Artifact Reduction (MAR) algorithm improved the visualization of titanium implants, which helps detect malplacements during procedures.
By End Use
The hospitals and specialty clinics segment accounted for a 68% share of the Fluoroscopy Equipment market in 2024. Hospitals remain the primary users due to their extensive patient base and advanced imaging infrastructure. The increasing number of complex surgical and interventional procedures supports continuous equipment upgrades. Specialty clinics are also adopting compact and mobile fluoroscopy systems to enhance procedural efficiency. Growing investment in modern imaging suites, combined with the need for faster diagnostics and integrated data management, continues to reinforce hospital dominance in this market segment.
Key Growth Drivers
Rising Demand for Minimally Invasive Procedures
The increasing preference for minimally invasive surgeries has significantly driven the fluoroscopy equipment market. Surgeons rely on real-time imaging to enhance procedural accuracy, reduce complications, and shorten recovery times. Fluoroscopy provides dynamic visualization essential for orthopedic, cardiovascular, and pain management procedures. The global rise in chronic diseases and trauma cases continues to expand surgical volumes, boosting demand for advanced fluoroscopy systems in hospitals and outpatient surgical centers.
For instance, GE HealthCare’s OEC 3D C-arm system captures a high-resolution 512³ voxel volume using a 200° isocentric sweep, enabling detailed 3D reconstructions during orthopedic and spinal surgeries. The system also includes advanced analysis tools and interfaces with navigation systems to assist with precise implant positioning.
Technological Advancements in Imaging Systems
Rapid innovations in fluoroscopic imaging technology are improving diagnostic precision and patient safety. The introduction of digital flat-panel detectors, dose-reduction algorithms, and AI-assisted image processing enhances workflow efficiency. These advancements allow clinicians to achieve clearer images with lower radiation exposure, improving both safety and performance. Manufacturers are focusing on hybrid imaging solutions that integrate fluoroscopy with CT or MRI for comprehensive visualization, driving equipment upgrades across medical institutions.
For instance, the Canon Medical Systems Ultimax-i system integrates an advanced 43 × 43 cm flat-panel detector and proprietary DoseRite technology to reduce patient radiation exposure. The system’s integrated Super Noise Reduction Filter (SNRF) processes images in real-time to maintain high image quality at a reduced dose.
Expanding Use in Orthopedic and Trauma Care
Fluoroscopy systems play a crucial role in orthopedic and trauma management due to their ability to provide real-time imaging during surgical procedures. Rising cases of bone fractures, sports injuries, and spinal disorders are fueling system demand. Hospitals increasingly rely on C-arms for precision in implant placement and alignment during orthopedic surgeries. The trend toward day-care surgeries and advanced rehabilitation centers is further enhancing the adoption of compact, mobile fluoroscopy devices.
Key Trends & Opportunities
Integration of Artificial Intelligence and Digital Platforms
AI integration is reshaping the fluoroscopy equipment landscape by improving image analysis and workflow automation. Smart imaging platforms can automatically adjust radiation doses, detect anatomical structures, and enhance contrast in real time. This reduces operator dependency and improves clinical outcomes. Additionally, digital connectivity allows seamless data sharing across departments, supporting telemedicine and remote diagnostics. The growing focus on smart, connected imaging solutions offers significant opportunities for system manufacturers.
For instance, Philips’ UNIQUE image processing in its fluoro systems dynamically adjusts exposure over 1,000 image segments per frame, optimizing balance between overexposed and underexposed zones. Their grid-controlled fluoroscopy mode cuts non-useful radiation by more than 20 mGy in routine abdominal scans while preserving diagnostic detail.
Rising Demand for Mobile and Compact Fluoroscopy Units
Healthcare facilities are increasingly adopting mobile fluoroscopy units for flexibility in surgical and diagnostic environments. Compact C-arms offer mobility, lower maintenance costs, and rapid deployment, making them suitable for smaller clinics and ambulatory surgical centers. Their ease of use and integration with digital data systems improve efficiency in emergency and trauma cases. The expanding network of outpatient facilities and the need for point-of-care imaging create strong growth opportunities for portable fluoroscopy systems.
For instance, Hologic Inc. launched its Fluoroscan InSight FD Mini C-Arm equipped with a 24 × 24 cm flat-panel detector. The system delivered 15-frame-per-second fluoroscopy and achieved sub-100 µm image resolution, enabling orthopedic surgeons to capture high-precision images during hand and wrist surgeries.
Key Challenges
High Equipment Cost and Maintenance Requirements
Fluoroscopy systems are capital-intensive, requiring significant investment in installation, calibration, and maintenance. Advanced digital and hybrid systems further increase procurement costs, limiting adoption in smaller healthcare facilities. Regular maintenance and radiation safety compliance also raise operational expenses. These financial barriers are particularly challenging in developing economies, where budget constraints and limited reimbursement policies slow equipment replacement and modernization cycles.
Radiation Exposure and Safety Concerns
Radiation exposure during fluoroscopic procedures remains a major safety challenge for both patients and healthcare staff. Despite technological improvements in dose management, prolonged use can still pose health risks. Hospitals must invest in shielding, monitoring, and staff training to meet regulatory safety standards. Continuous focus on balancing image quality with minimal radiation levels is essential for improving long-term safety outcomes and sustaining clinical confidence in fluoroscopic imaging.
Regional Analysis
North America
North America held a 38% share of the fluoroscopy equipment market in 2024, driven by high healthcare spending and advanced medical infrastructure. The region benefits from strong adoption of digital fluoroscopy systems and increased demand for minimally invasive surgeries. The United States leads the market due to the presence of major manufacturers, well-established hospitals, and favorable reimbursement policies. Growing emphasis on radiation dose reduction and AI-based image enhancement supports continuous equipment upgrades. Ongoing investments in hybrid operating rooms and image-guided surgery centers further strengthen the region’s dominance in diagnostic imaging technologies.
Europe
Europe accounted for a 29% market share in 2024, supported by rising demand for real-time imaging in orthopedic and cardiovascular procedures. The region’s focus on improving patient safety and reducing radiation exposure has accelerated the transition to digital fluoroscopy. Germany, France, and the United Kingdom lead the market through strong healthcare infrastructure and growing investments in hospital modernization. Increasing regulatory emphasis on radiation management and the expansion of specialized diagnostic centers continue to drive market growth across Western and Northern Europe.
Asia-Pacific
Asia-Pacific captured a 27% share of the fluoroscopy equipment market in 2024, fueled by the rapid expansion of healthcare infrastructure and medical imaging capabilities. China, Japan, India, and South Korea are key contributors, with rising demand for minimally invasive and image-guided procedures. Increasing government investments in public hospitals and diagnostic facilities are driving adoption of mobile and digital C-arm systems. The growing burden of trauma, orthopedic, and cardiac conditions also supports equipment deployment. Continuous advancements in affordable, portable fluoroscopy units are making imaging technology more accessible across developing economies.
Rest of the World
The Rest of the World region represented a 6% share of the fluoroscopy equipment market in 2024. Growth is primarily supported by rising healthcare investments in Latin America and the Middle East. Brazil, Mexico, and the United Arab Emirates are witnessing steady improvements in hospital imaging capacity and technology upgrades. Although limited access and budget constraints hinder widespread adoption, expanding private healthcare facilities and international partnerships are improving market penetration. Increased awareness of image-guided procedures and gradual adoption of digital radiology systems create long-term opportunities for regional market expansion.
Market Segmentations:
By Product
Fluoroscopy Devices
C-arms
By Application
Orthopedic
Cardiovascular
Pain Management & Trauma
Others
By End Use
Hospitals & Specialty Clinics
Diagnostic Imaging centers
Others
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Competitive Landscape
The competitive landscape of the Fluoroscopy Equipment market is defined by key players such as GE HealthCare, Siemens Healthineers, Koninklijke Philips NV, Canon Medical Systems Corporation, Hitachi Medical Systems, Shimadzu Corporation, Ziehm Imaging GmbH, Hologic Inc., Orthoscan Inc., and Carestream Health. These companies compete through continuous innovation in digital fluoroscopy systems, radiation dose optimization, and hybrid imaging solutions. GE HealthCare and Siemens Healthineers lead with extensive product portfolios integrating AI and advanced detector technology for enhanced imaging precision. Philips and Canon focus on compact and mobile fluoroscopy units to expand accessibility in smaller healthcare facilities. Meanwhile, Ziehm Imaging and Orthoscan specialize in portable C-arms designed for orthopedic and trauma applications. Partnerships, R&D investments, and software-driven workflow optimization remain central to competitive differentiation. Overall, the market’s competition emphasizes image quality, patient safety, and seamless integration with hospital information systems to meet evolving clinical and regulatory standards.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In July 2025, Siemens Healthineers received FDA clearance for its Luminos Q.namix R and Luminos Q.namix T systems, combining radiography and fluoroscopy capabilities in one platform.
In March 2025, GE HealthCare partnered with NVIDIA to co-develop autonomous X-ray and ultrasound imaging using the Isaac for Healthcare simulation platform.
In December 2024, Siemens Healthineers launched the Luminos Q.namix 1 platform as its next-generation integrated fluoroscopy/radiography system.
In July 2023, Canon Medical Systems launched a multipurpose fluoroscopic table with new functions, Zexira i9 digital X-ray RF system. It is a digital X-ray RF system which is equipped with all the essential features to meet clinical demands.
Report Coverage
The research report offers an in-depth analysis based on Product, Application, End Use and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
The demand for advanced fluoroscopy systems will grow with the rise in image-guided surgeries.
Manufacturers will focus on AI-based imaging tools to improve accuracy and reduce radiation exposure.
Mobile and compact fluoroscopy units will gain popularity in outpatient and trauma care facilities.
Hybrid imaging solutions combining fluoroscopy with CT or MRI will become more common in hospitals.
Continuous R&D investment will enhance image quality, workflow efficiency, and system connectivity.
Asia-Pacific will see rapid market expansion due to healthcare modernization and technology upgrades.
North America and Europe will continue leading through high adoption of digital imaging systems.
Companies will strengthen partnerships to expand service networks and after-sales support.
Government initiatives promoting radiation safety will encourage the replacement of legacy systems.
Sustainability efforts will push the development of low-dose, energy-efficient fluoroscopy technologies.
1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope
2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology
3. Executive Summary
4. Introduction
4.1. Overview
4.2. Key Industry Trends
5. Global Fluoroscopy Equipment Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast
9. Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Market Trends
9.1.1.2. Market Forecast
9.1.2. Canada
9.1.2.1. Market Trends
9.1.2.2. Market Forecast
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Indonesia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast
12. Porter’s Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes
13. Price Analysis
14. Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. GE HealthCare
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. Financials
14.3.1.4. SWOT Analysis
14.3.2. Shimadzu Corporation
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. Financials
14.3.2.4. SWOT Analysis
14.3.3. Hologic Inc.
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. Financials
14.3.3.4. SWOT Analysis
14.3.4. Canon Medical Systems Corporation
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. Financials
14.3.4.4. SWOT Analysis
14.3.5. Ziehm Imaging GmbH
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. Financials
14.3.5.4. SWOT Analysis
14.3.6. Koninklijke Philips NV
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. Financials
14.3.6.4. SWOT Analysis
14.3.7. Orthoscan Inc.
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. Financials
14.3.7.4. SWOT Analysis
14.3.8. Carestream Health
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. Financials
14.3.8.4. SWOT Analysis
14.3.9. Hitachi Medical Systems
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. Financials
14.3.9.4. SWOT Analysis
14.3.10. Siemens Healthineers
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. Financials
14.3.10.4. SWOT Analysis
15. Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions
What is the current market size for the Fluoroscopy Equipment market, and what is its projected size in 2032?
The Fluoroscopy Equipment market was valued at USD 2.06 billion in 2024 and is projected to reach USD 2.37 billion by 2032.
At what Compound Annual Growth Rate is the Fluoroscopy Equipment market projected to grow between 2025 and 2032?
The Fluoroscopy Equipment market is expected to grow at a CAGR of 1.8% during the forecast period.
Which Fluoroscopy Equipment market segment held the largest share in 2024?
The C-arms segment led the Fluoroscopy Equipment market in 2024 with a 57% share due to its flexibility and clinical utility.
What are the primary factors fueling the growth of the Fluoroscopy Equipment market?
The Fluoroscopy Equipment market growth is driven by rising minimally invasive procedures, digital imaging innovations, and improved radiation management.
Who are the leading companies in the Fluoroscopy Equipment market?
The major players in the Fluoroscopy Equipment market include GE HealthCare, Siemens Healthineers, Philips, Canon Medical Systems, and Shimadzu Corporation.
Which region commanded the largest share of the Fluoroscopy Equipment market in 2024?
The North America region dominated the Fluoroscopy Equipment market in 2024 with a 38% share, supported by strong healthcare infrastructure and technology adoption.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The Dental Impression Systems market size was valued at USD 1.87 billion in 2024 and is anticipated to reach USD 3.78 billion by 2032, growing at a CAGR of 9.2% during the forecast period.
Fluorescence in situ hybridization (FISH) probe market size was valued at USD 946.52 million in 2024 and is anticipated to reach USD 1,648.66 million by 2032, at a CAGR of 7.28% during the forecast period.
The Fondaparinux market size was valued at USD 686.65 million in 2024 and is anticipated to reach USD 1,107.44 million by 2032, growing at a CAGR of 6.3% during the forecast period.
The Healthcare Software as a Service market size was valued at USD 28.49 billion in 2024 and is anticipated to reach USD 70.54 billion by 2032, growing at a CAGR of 12% during the forecast period.
The Psychometric Assessments Services market size was valued at 5,700.00 million in 2018, increasing to 6,888.37 million in 2024, and is projected to reach 11,625.24 million by 2032, growing at a CAGR of 6.82% during the forecast period.
The North America Psychometric Assessments Services Market size was valued at USD 2,091.90 million in 2018, increased to USD 2,497.68 million in 2024, and is projected to reach USD 4,209.52 million by 2032, registering a CAGR of 6.6% during the forecast period (2025–2032).
France Compounding Pharmacies Market size was valued at USD 422.73 Million in 2018 to USD 569.57 Million in 2024 and is anticipated to reach USD 834.42 Million by 2032, at a CAGR of 4.55% during the forecast period.
Europe Psychometric Assessments Services market size was valued at USD 1,413.60 million in 2018 and increased to USD 1,637.87 million in 2024. The market is anticipated to reach USD 2,601.18 million by 2032, registering a CAGR of 5.9% during the forecast period.
Australia Compounding Pharmacies Market size was valued at USD 67.82 million in 2018 and grew to USD 106.69 million in 2024. It is anticipated to reach USD 197.42 million by 2032, at a CAGR of 7.45% during the forecast period.
Australia Psychometric Assessments Services market size was valued at USD 58.05 million in 2018 and increased to USD 72.87 million in 2024. It is anticipated to reach USD 128.68 million by 2032, registering a CAGR of 7.37% during the forecast period.
U.S. Compounding Pharmacies market size was valued at USD 3,293.81 Million in 2018, rising to USD 4,743.43 Million in 2024, and is anticipated to reach USD 7,651.56 Million by 2032, growing at a CAGR of 5.73% during the forecast period.
The UK Compounding Pharmacies market was valued at USD 173.65 million in 2018 and grew to USD 237.16 million in 2024. The market is projected to reach USD 354.16 million by 2032, registering a CAGR of 4.79% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$6999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
